{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:50:30Z","timestamp":1777567830317,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["275849 \/ 470980"],"award-info":[{"award-number":["275849 \/ 470980"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejphar.2020.173489","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T11:16:02Z","timestamp":1597749362000},"page":"173489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Enantiomeric N-substituted phthalimides with excitatory amino acids protect zebrafish larvae against PTZ-induced seizures"],"prefix":"10.1016","volume":"888","author":[{"given":"Carolina","family":"Campos-Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ek","family":"Fredrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Ramirez-San Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173489_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"Afrikanova","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173489_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuint.2005.04.025","article-title":"Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment","volume":"47","author":"Ahmed","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2020.173489_bib3","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00044-013-0870-3","article-title":"Synthesis and antiseizure evaluation of isoindoline-1,3-dione derivatives in mice","volume":"23","author":"Aliabadi","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejphar.2020.173489_bib4","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/bjp.2008.249","article-title":"Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery","volume":"154","author":"Barros","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173489_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2007.03.015","article-title":"Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants","volume":"75","author":"Berghmans","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2020.173489_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1573406414666180525082038","article-title":"Neuropharmacological screening of chiral and non-chiral phthalimide- containing compounds in mice: in vivo and in silico experiments","volume":"15","author":"Campos-Rodr\u00edguez","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173489_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2016.07.018","article-title":"Characterization of the \u03b3-aminobutyric acid signaling system in the zebrafish (Danio rerio Hamilton) central nervous system by reverse transcription-quantitative polymerase chain reaction","volume":"343","author":"Cocco","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173489_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ntt.2012.03.002","article-title":"Locomotor activity assay in zebrafish larvae: influence of age, strain and ethanol","volume":"34","author":"de Esch","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ejphar.2020.173489_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acschemneuro.6b00014","article-title":"Behavioral analysis of dopaminergic activation in zebrafish and rats reveals similar phenotypes","volume":"7","author":"Ek","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173489_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077548","article-title":"Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish","volume":"8","author":"Fleming","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173489_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2017.10.004","article-title":"The developing utility of zebrafish models of neurological and neuropsychiatric disorders: a critical review","volume":"299","author":"Fontana","year":"2018","journal-title":"Exp. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.ejphar.2020.173489_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/epi.12295","article-title":"Epilepsy therapy development: technical and methodologic issues in studies with animal models","volume":"54","author":"Galanopoulou","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2020.173489_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-2999(91)90152-G","article-title":"MK-801 prevents chemical kindling induced by pentylenetetrazol in rats","volume":"193","author":"Giorgi","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173489_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/17460440902988464","article-title":"Using zebrafish to assess the impact of drugs on neural development and function","volume":"4","author":"Guo","year":"2009","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173489_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0968-0896(01)00308-X","article-title":"Structural development of biological response modifiers based on thalidomide","volume":"10","author":"Hashimoto","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173489_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/acschemneuro.9b00524","article-title":"Discovery of procognitive antipsychotics by combining muscarinic M 1 receptor structure\u2013activity relationship with systems response profiles in zebrafish larvae","volume":"11","author":"Hellman","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173489_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7146907","article-title":"Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid","volume":"218","author":"Iadarola","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173489_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.pbb.2012.12.010","article-title":"Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish","volume":"103","author":"Irons","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2020.173489_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.brainresbull.2007.10.043","article-title":"Functional and developmental analysis of the blood\u2013brain barrier in zebrafish","volume":"75","author":"Jeong","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2020.173489_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tips.2013.12.002","article-title":"Zebrafish as an emerging model for studying complex brain disorders","volume":"35","author":"Kalueff","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2020.173489_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7324\/JAPS.2016.60330","article-title":"Recent advances and future prospects of phthalimide derivatives","author":"Kushwaha","year":"2016","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2020.173489_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00044-013-0730-1","article-title":"Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes","volume":"23","author":"Leite","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejphar.2020.173489_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2016.05.007","article-title":"Crossing the blood\u2013brain\u2013barrier with transferrin conjugated carbon dots: a zebrafish model study","volume":"145","author":"Li","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejphar.2020.173489_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd4627","article-title":"Zebrafish as tools for drug discovery","volume":"14","author":"MacRae","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173489_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"Melchert","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173489_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0773.1993.tb01639.x","article-title":"Effects of dopamine D 1 and D 2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice","volume":"72","author":"\u00d6gren","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173489_bib27","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1038\/s41598-017-03144-7","article-title":"Action sequencing in the spontaneous swimming behavior of zebrafish larvae - implications for drug development","volume":"7","author":"Palm\u00e9r","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173489_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuroscience.2013.11.040","article-title":"Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy","volume":"259","author":"Rahn","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173489_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/dneu.20910","article-title":"Behavioral screening for neuroactive drugs in zebrafish","volume":"72","author":"Rihel","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.ejphar.2020.173489_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2020.173489_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresbull.2011.11.020","article-title":"Perspectives of zebrafish models of epilepsy: what, how and where next?","volume":"87","author":"Stewart","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2020.173489_bib32","series-title":"Epilepsy [WWW Document]","author":"World Health Organization","year":"2019"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:57:39Z","timestamp":1777402659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920305811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S0014299920305811"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173489","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enantiomeric N-substituted phthalimides with excitatory amino acids protect zebrafish larvae against PTZ-induced seizures","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173489"}}